BELLSHILL, SCOTLAND, 31 January 2013: Link Technologies Ltd, a specialist manufacturer of oligonucleotide reagents and precursors, has announced Zirench Technology Co. Ltd as distributor in China, the first Asian distributor for its comprehensive range of products. Located in Dalian City, Zirench Technology will represent Link Technologies in China, expanding their reach across the country and providing invaluable local support for customers.
The appointment of Zirench Technology is the first signing of multiple, upcoming distributorship agreements in the Far East, and is testament to Link Technologies’ on-going strategic development and growth. As an ISO 9001:2008 certified supplier of products for oligonucleotide synthesis, Link Technologies is committed to providing all customers with high purity, reliable oligo precursors and reagents, which can now extend to customers in China, thanks to Zirench Technology.
Commenting on the new distributor agreement, Dr John Bremner, CEO at Link Technologies, said: “We are working hard to effectively deliver our products to customers in research and industrial institutions in Asia and other parts of the world, where easily accessible local support and expertise is very important. We are delighted that this deal with Zirench boosts this strategy.”
Dr Victor Liu, Commercial Manager at Zirench Technology, added “Our aim is to offer our customers laboratory instruments, supplies and biological agents of world-class quality. As such, we were keen to act on behalf of Link Technologies, to raise awareness of and distribute their high quality oligo precursor products across China.” Providing a broad catalogue of reagents for DNA, RNA and PNA synthesis, Link Technologies has particular expertise in the manufacture of modified nucleic acid products, often unavailable elsewhere.
For more information, please visit the Link Technologies website at www.linktech.co.uk or follow us on Twitter: @linktechdna.
About Link Technologies Ltd
Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.
Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.
For further information see: www.linktech.co.uk.
